Skip to main content

Table 2 Baseline characteristics of dogs on two different enzyme treatments for canine exocrine pancreatic insufficiency

From: A blinded randomised controlled trial to determine the effect of enteric coating on enzyme treatment for canine exocrine pancreatic insufficiency

Criterion Test treatment (coated) Control treatment (uncoated) P value
Breed Border collie (1), CKCS (1), Akita (2), CKCS (1), ---
Cocker spaniel (1), Dogues de Bordeaux (1),
GSD (12), Lhasa apso (1), mixed breed (2) GSD (13), mixed breed (2)
West Highland white terrier (1) Tibetan terrier (1)
Sex Male (8) Male (5) 0.329
Neutered male (4) Neutered male (3)
Female (2) Female (7)
Neutered female (5) Neutered female (5)
Age (months) 41 (12 to 108) 48 (11 to 144) 0.829
Cobalamin1 Hypocobalaminemic (5), normocobalaminemic (9), Hypocobalaminemic (7), normocobalaminemic (9), 0.668
  Not measured (6) Not measured (4)  
  1. The table reports signalment and cobalamin status in dogs, with exocrine pancreatic insufficiency, randomised to receive one of two enzyme treatments (test e.g. coated and control e.g. uncoated). Numerical data are expressed as median (range). CKCS: Cavalier King Charles Spaniel; GSD: German Shepherd Dog. 1Given that various laboratories were used (with different reference ranges), cobalamin data expressed in categories (e.g. normcobalaminaemia, hypocobalaminaemia) rather than as absolute concentrations. There were no differences between groups for any of the baseline parameters.